SEC Form 4 · accession 0001209191-15-023280
MELINTA THERAPEUTICS, INC. /NEW/ · MLNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Moore
Officer — Chief Commercial Officer
Period of report
Mar 4, 2015
Accepted (ET)
Mar 6, 2015 · 8:03 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001461993
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 4, 2015 | A | 1,000 | $32.59 | A | 1,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $23.51 | holding | — | — | — | — | Dec 31, 2024 | Common Stock | 36,363 | 36,363 | D |
| Employee Stock Option (Right to Buy)F2 | $12.79 | holding | — | — | — | — | Jan 1, 2024 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option vests on the following schedule: 1/48th of the shares shall vest at the end of each month over 48th months, beginning after 01/01/2015.
- F2The option vests according to the following schedule: 25,000 shares vested immediately on January 2, 2014 and 18,750 shares vest in one year annual installments, beginning January 2, 2015.